Bioresorbable Vascular Stents and Drug-Eluting Stents in Treatment of Coronary Heart Disease: A Meta-Analysis

Journal of Cardiothoracic Surgery - United Kingdom
doi 10.1186/s13019-020-1041-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease *

Sultan Qaboos University Medical Journal
Medicine
2016English

Downstream Coronary Effects of Drug-Eluting Stents

American Heart Journal
Cardiovascular MedicineCardiology
2011English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Identification of Functional Modules Induced by Bare-Metal Stents and Paclitaxel-Eluting Stents in Coronary Heart Disease

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Head-To-Head Comparison of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies

PLoS ONE
Multidisciplinary
2014English

Hybrid Coronary Percutaneous Treatment With Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results From the GABI-R Registry

Journal of Clinical Medicine
2019English

Recent Advances in Drug Eluting Stents

International Journal of Pharmaceutics
Pharmaceutical Science
2013English

Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy